Sharekhan

BUY NOW Buy Fredun Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Fredun Pharmaceuticals Ltd

Wed 24/06/2026,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Fredun Pharmaceuticals Ltd

Your Vote -

Buy

40.00%

Hold

40.00%

Sell

20.00%

40.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Jun 2026, 7:29PM Transcript of the Earnings conference call held on 10th June 2026 for Q4 FY26.

  • Fredun Pharma. has declared 7% Final dividend for the financial year March 2026

    11 Jun 2026, 7:04AM Fredun Pharmaceuticals Ltd. on Monday, 25 May 2026, has announced Final dividend of 7 percent on Equity Share, to its shareholders holding shares on t

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Jun 2026, 7:03PM Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call'\r\n\r\n\r\n

  • Fredun Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20

    8 Jun 2026, 7:57PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (\SEBI Listing Regulations\)

  • Fredun Pharma. - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26

    8 Jun 2026, 7:37PM Intimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26

  • Fredun Pharma. - Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM).

    8 Jun 2026, 7:33PM Notice of Book Closure for the purpose of 39th Annual General Meeting (AGM)

  • Fredun Pharma. - Notice Convening 39Th Annual General Meeting ('AGM') Of Fredun Pharmaceuticals Limited

    8 Jun 2026, 4:57PM Notice convening 39th Annual General Meeting (\AGM\) of Fredun Pharmaceuticals Limited

  • Fredun Pharma. - Reg. 34 (1) Annual Report.

    8 Jun 2026, 4:54PM Annual Report of Fredun Pharmaceuticals Limited for the Financial Year 2025-2026 including the Notice of the 39th Annual General Meeting of the Compan

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Jun 2026, 11:28AM Revised intimation of Earnings Conference Call for the quarter Q4 of FY26.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jun 2026, 5:42PM Intimation of Earnings Conference Call for the quarter Q4 of FY 2026.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 Jun 2026, 3:16PM Intimation of Earning Conference call for the quarter Q4 of FY 2026.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    25 May 2026, 10:06PM Re-appointment of Internal Auditor and Cost Auditor of the Company for the FY 2026-2027.

  • Fredun Pharma. - Revised Outcome.

    25 May 2026, 9:53PM Revised Outcome.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 May 2026, 5:55PM Press Release titled Fredun Pharmaceuticals Announces 2:1 Bonus Issue, Signaling Strong Growth Confidence

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 May 2026, 5:50PM Press Release title Fredun Pharmaceuticals Delivers Robust FY 26 Performance; Revenue Jumps 40%, EBITDA Surges 72% and Profit Rises ~60% YoY

  • Fredun Pharma. Q4 net profit jumps 56.58% at Rs 11.07 cr

    25 May 2026, 3:30PM The company reported standalone net profit of Rs 11.07 crore for the quarter ended March 31, 2026 as compared to Rs 7.07 crore in the same period last

  • Fredun Pharma. - Audited Results For The Quarter And Year Ended On 31St March, 2026.

    25 May 2026, 3:07PM Audited Results for the quarter and year ended on 31st March, 2026.

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May, 2026

    25 May 2026, 2:58PM Outcome of Board Meeting held on 25th May, 2026

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 May 2026, 10:31PM Fredun Pharmaceuticals Limited Unveils Cellular Longetivity Dedicated Platform Daulcel

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 May 2026, 10:29PM Fredun Pharmaceuticals Limited announces Strategic Launch of Hormone Range Products.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    15 May 2026, 10:28PM Monitoring Agency report for the quarter ended 31st March 2026.

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026

    15 May 2026, 10:25PM The Board of Directors of the Company at their Board Meeting held on Friday, May 15, 2026 at 07:30 P.M through Video Conferencing (VC) inter alia tran

  • Fredun Pharma. - Board Meeting Intimation for The Meeting To Be Held On Monday, 25 May, 2026.

    15 May 2026, 1:09PM Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consid

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    29 Apr 2026, 11:25AM Please find enclosed press release titled \Fredun Pharmaceuticals Expands Manufacturing Base with Fifty Facility at Palghar\ issued by Fredun Pharmace

  • Fredun Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    28 Apr 2026, 2:49PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended April 09, 2026

    24 Apr 2026, 4:40PM As of April 2026, 44.57% is owned by Indian Promoters and 55.43% by Public. <p align=justify> Top three Promoters holding highest number of shares of

  • Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    17 Apr 2026, 5:30PM As of March 2026, 44.17% is owned by Indian Promoters and 55.83% by Public. <p align=justify> Top three Promoters holding highest number of shares of

  • Fredun Pharma. - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

    13 Apr 2026, 6:00PM Disclousre Under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Allotment

    9 Apr 2026, 6:56PM Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Conversion of Securities

    9 Apr 2026, 6:53PM Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 09Th April, 2026

    9 Apr 2026, 6:48PM Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares

  • Fredun Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Apr 2026, 5:36PM In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder certificate dated 01st April,2026

  • Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 25, 2026

    1 Apr 2026, 9:40PM As of March 2026, 44.17% is owned by Indian Promoters and 55.83% by Public. <p align=justify> Top three Promoters holding highest number of shares of

  • Fredun Pharma. - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

    26 Mar 2026, 6:49PM Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates

    25 Mar 2026, 7:30PM Outcome of the Analyst/Investors Meet.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Allotment

    25 Mar 2026, 6:07PM Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.

  • Fredun Pharma. - Announcement under Regulation 30 (LODR)-Conversion of Securities

    25 Mar 2026, 6:02PM Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.

  • Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 25Th March, 2026

    25 Mar 2026, 5:51PM Allotment of 1,06,668 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 500.7423 307.8076 226.9811 182.9008 120.825
Liabilities 500.7423 307.8076 226.9811 182.9008 120.825
Equity 5.4727 4.7217 4.6992 4.5323 4.4326
Gross Profit 91.1373 52.6457 37.9823 27.7774 13.7953
Net Profit 33.2069 20.8075 15.6234 10.8066 6.3353
Cash From Operating Activities 16.438 -28.8833 -0.4387 -14.4088 -2.3802
NPM(%) 5.22 4.58 4.48 3.93 2.82
Revenue 635.4657 453.8174 348.1562 274.6756 224.4595
Expenses 544.3284 401.1717 310.1739 246.8982 210.6642
ROE(%) 12.56 7.87 5.91 4.08 2.39

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 714.00 -0.56 0.00 1424.18 -26.19 0.70
Lotus Eye Hospital and Institute Ltd 129.25 4.40 4268.67 5189.51 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.75 -2.37 0.00 10775.13 -39.50 0.00
Astec Lifesciences Ltd 750.10 -2.26 0.00 4893.83 -363.14 0.00

Company Info

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.

Read More

Parent Organisation

Fredun Pharmaceuticals Ltd.

Founded

08/06/1987

Managing Director

Dr.(Mrs.)Daulat N Medhora

NSE Symbol

FAQ

The current price of Fredun Pharmaceuticals Ltd is

The 52-week high for Fredun Pharmaceuticals Ltd is

The market capitalization of Fredun Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fredun Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fredun Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fredun Pharmaceuticals Ltd shares.

The CEO of Fredun Pharmaceuticals Ltd is Dr.(Mrs.)Daulat N Medhora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

Invest Better, Trade Faster — Install Now.

Mirae Asset Sharekhan App

Recommended

Open App

Browser

Continue
OPEN FREE* DEMAT ACCOUNT